James Russell Uhl, DO in Pleasant Grove, UT - Anesthesiology

James Russell Uhl, DO is a Anesthesiology physician based in Pleasant Grove, Utah. James Russell Uhl is licensed to practice in Utah (license number 180349-1204) and his current practice location is 2386 N 1560 W, Pleasant Grove, Utah. He can be reached at his office (for appointments etc.) via phone at (801) 785-0263.

NPI number for James Russell Uhl is 1578531497 and his current mailing address is Po Box 1648, American Fork, Utah. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1578531497.

Contact Information

	James Russell Uhl, DO
	2386 N 1560 W, Pleasant Grove, UT 84062-5027
	(801) 785-0263
	Not Available

Physician's Profile

Full Name	James Russell Uhl
Gender	Male
Speciality	Anesthesiology
Location	2386 N 1560 W, Pleasant Grove, Utah
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1578531497
Provider Enumeration Date: 03/08/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for James Russell Uhl such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1578531497	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207L00000X	Anesthesiology	180349-1204 (Utah)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. James Russell Uhl is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
James Russell Uhl, DO Po Box 1648, American Fork, UT 84003-6648 Ph: () -	James Russell Uhl, DO 2386 N 1560 W, Pleasant Grove, UT 84062-5027 Ph: (801) 785-0263

News Archive

Genomic analysis provides clues about SARS-CoV-2 ancestry and transmission

Researchers in the UK conducting a genomic analysis of severe acute respiratory virus syndrome coronavirus 2 (SARS-CoV-2) and SARS-like coronaviruses in the bat and pangolin have identified strong host-associated divergences that could provide clues about the ancestry and interspecies transmission of SARS-CoV-2.

South Africa's science minister urges African researchers to become more involved in solving continent's health problems

"South Africa's science minister, Naledi Pandor, has called for increased efforts by African nations to build both a greater ability to carry out research relevant to their specific health challenges, and the capacity to put such research to use," SciDev.Net reports.

Investing in new hepatitis C therapies may have significant economic impact

While a new generation of safer, more effective oral medications to treat hepatitis C patients may cost tens of thousands of dollars for a 12-week regiment, investing in these new therapies could generate savings estimated at more than $3.2 billion annually in the U.S. and five European countries, according to a new study (abstract 228) released today at Digestive Disease Week® (DDW) 2015.

Cost effective moisturizers could help prevent eczema in high-risk newborns

What if it was possible to prevent your child from getting eczema - a costly, inflammatory skin disorder - just by applying something as inexpensive as petroleum jelly every day for the first six months of his or her life?

James Russell Uhl, DO - Anesthesiology in Pleasant Grove, UT